The immunomodulatory and regenerative properties of mesenchymal stromal cells (MSCs)
make MSC therapy a promising therapeutic strategy in kidney disease. A targeted MSC …

Purpose Adipose-derived mesenchymal stromal cells (MSCs) have emerged as promising
tools for peripheral nerve reconstruction. There is a paucity of information regarding the …

Objective: To systematically evaluate the efficacy of mesenchymal stem cells (MSCs) for
acute kidney injury (AKI) in preclinical studies and to explore the optimal transplantation …

Recent approaches of regenerative medicine can offer a therapeutic option for patients
undergoing acute kidney injury. In particular, mesenchymal stem cells were shown to …

Backgrounds Despite the potential therapeutic benefits, cell therapy in renal ischemia-
reperfusion (I/R) injury is currently limited by low rates of cell engraftment after systemic …

Mesenchymal stem cells (MSCs) isolated from various tissues are currently regarded as one
of the most convenient starting materials for preparation of cell therapy and tissue …

The kidney is a specialized low-regenerative organ with several different types of cellular
lineages; however, the identity of renal stem/progenitor cells with nephrogenic potential and …

Interventional regenerative medicine (IRM) uses image-guided, minimally invasive
procedures for the targeted delivery of stem cell–based therapies to regenerate, replace, or …

Recently, mesenchymal stem cells (MSCs) are increasingly used as a panacea for multiple
types of disease short of effective treatment. Dozens of clinical trials published demonstrated …

Mesenchymal stromal/stem cell (MSC) therapy has been thoroughly tested in preclinical
animal models and holds great promise for the treatment of kidney diseases. It is becoming …